Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
3.020
-0.100 (-3.21%)
At close: Jul 10, 2025, 4:00 PM
2.990
-0.030 (-0.99%)
Pre-market: Jul 11, 2025, 4:24 AM EDT

Bone Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-4.26-4.11-8.95-1.48-1.61-1.82
Upgrade
Stock-Based Compensation
0.190.190.150.270.21-
Upgrade
Other Operating Activities
-0.02-0.05-0.89-2.180.51
Upgrade
Change in Accounts Payable
0.150.090.260-0.370.33
Upgrade
Change in Unearned Revenue
---0.780.78--
Upgrade
Change in Other Net Operating Assets
0.2-0.240.66-0.960.050.07
Upgrade
Operating Cash Flow
-3.75-4.12-9.56-3.57-1.23-0.43
Upgrade
Short-Term Debt Issued
-----0.01
Upgrade
Long-Term Debt Issued
----1.060.39
Upgrade
Total Debt Issued
----1.060.4
Upgrade
Short-Term Debt Repaid
-----0.01-
Upgrade
Total Debt Repaid
-----0.01-
Upgrade
Net Debt Issued (Repaid)
----1.050.4
Upgrade
Issuance of Common Stock
3.274.425.044.436.86-
Upgrade
Financing Cash Flow
3.274.425.044.437.90.4
Upgrade
Net Cash Flow
-0.480.3-4.510.866.68-0.02
Upgrade
Free Cash Flow
-3.75-4.12-9.56-3.57-1.23-0.43
Upgrade
Free Cash Flow Per Share
-10.47-16.31-217.89---
Upgrade
Cash Interest Paid
----0.01-
Upgrade
Levered Free Cash Flow
-2.25-2.73-7.21-0.99--
Upgrade
Unlevered Free Cash Flow
-2.25-2.73-7.21-0.53--
Upgrade
Change in Net Working Capital
-0.280.281.47-1.49--
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q